Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation

Area of Science:

• Biomaterials Science
• Medical Devices
• Cardiovascular Research

Background:

• Thrombosis and restenosis are significant complications following vascular interventions.
• Current treatments often have limitations in efficacy and side effects.
• Localized and sustained nitric oxide (NO) delivery presents a promising therapeutic strategy.

Purpose of the Study:

• To develop and characterize polymeric biomaterials for sustained nitric oxide (NO) production.
• To investigate the efficacy of these NO-releasing materials in inhibiting platelet adhesion and smooth muscle cell proliferation in vitro.
• To evaluate the potential of these materials in preventing thrombosis and restenosis.

Main Methods:

• Covalent incorporation of three NO donors with varying half-lives into photopolymerized polyethylene glycol hydrogels.
• Characterization of NO production kinetics under physiological conditions.
• In vitro assessment of smooth muscle cell proliferation and platelet adhesion to NO-treated surfaces.

Main Results:

• Polyethylene glycol hydrogels demonstrated sustained NO production over periods ranging from hours to months, dependent on formulation.
• NO production was inhibited at acidic pH, suggesting potential for material storage.
• The NO-releasing hydrogels effectively inhibited smooth muscle cell growth in culture.
• Exposure to NO-producing hydrogels significantly reduced platelet adhesion to collagen-coated surfaces in whole blood.

Conclusions:

• Developed polymeric biomaterials provide localized and sustained nitric oxide (NO) release.
• These NO-releasing hydrogels show significant potential for inhibiting key cellular events contributing to thrombosis and restenosis.
• The materials offer a promising therapeutic approach for preventing complications after vascular procedures like balloon angioplasty.